Mark D. Rothmann
Impact in
- Statistics and Probability top 0.5%
- Statistical Methods in Clinical Trials
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Papers in
-
- Statistical Methods in Clinical Trials 23
- Probability and Statistical Research 12
- Statistical Methods and Bayesian Inference 3
- Statistical Methods and Inference 2
-
- Stochastic processes and statistical mechanics 6
- Co-authors
- Richard Pazdur (11 shared papers)Thomas R. Fleming (6 shared papers)Gang Chen (3 shared papers)Jogarao V. S. Gobburu (4 shared papers)Hong Laura Lu (2 shared papers)Martin H. Cohen (4 shared papers)Hsiao‐Hui Tsou (2 shared papers)John R. Johnson (3 shared papers)
- Journals
- Clinical Cancer Research (6 papers)Journal of Biopharmaceutical Statistics (6 papers)Pharmaceutical Statistics (4 papers)Statistics in Medicine (3 papers)Statistics in Biopharmaceutical Research (3 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Mark D. Rothmann
48 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 112
- Statistics and Probability 509
- Hematology 325
- Gastroenterology 112
- Genetics 109
- Pharmacology 111
Countries citing papers authored by Mark D. Rothmann
This map shows the geographic impact of Mark D. Rothmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Rothmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Rothmann more than expected).
Fields of papers citing papers by Mark D. Rothmann
This network shows the impact of papers produced by Mark D. Rothmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Rothmann. The network helps show where Mark D. Rothmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Rothmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. | 2002 | 410 |
| 2 | 2013 | 210 | |
| 3 | Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. | 2002 | 204 |
| 4 | 2002 | 192 | |
| 5 | 2012 | 187 | |
| 6 | 2009 | 148 | |
| 7 | 2012 | 123 | |
| 8 | 2011 | 96 | |
| 9 | Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. | 2003 | 89 |
| 10 | 2013 | 86 | |
| 11 | 2010 | 80 | |
| 12 | 2008 | 74 | |
| 13 | 2011 | 66 | |
| 14 | 2015 | 54 | |
| 15 | 2011 | 36 | |
| 16 | 2008 | 33 | |
| 17 | 2012 | 28 | |
| 18 | 2001 | 24 | |
| 19 | 2003 | 20 | |
| 20 | 2022 | 13 |
About Mark D. Rothmann
Mark D. Rothmann is a scholar working on Statistics and Probability, Mathematical Physics, Hematology, Genetics and Management Information Systems, having authored 51 papers that have together received 2.3k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (23 papers), Probability and Statistical Research (12 papers), Stochastic processes and statistical mechanics (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Advanced Queuing Theory Analysis (3 papers), Probability and Risk Models (3 papers), Statistical Methods and Bayesian Inference (3 papers) and Statistical Methods and Inference (2 papers). The work is most often cited by research in Statistics and Probability (509 citations), Hematology (325 citations), Gastroenterology (112 citations), Genetics (109 citations) and Pharmacology (111 citations). Mark D. Rothmann has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Richard Pazdur, Thomas R. Fleming, Gang Chen, Jogarao V. S. Gobburu, Hong Laura Lu, Martin H. Cohen, Hsiao‐Hui Tsou, John R. Johnson, Brian L. Wiens and Ning Li. Their work appears in journals such as Clinical Cancer Research, Journal of Biopharmaceutical Statistics, Pharmaceutical Statistics, Statistics in Medicine and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.